Results 221 to 230 of about 33,699 (271)
Some of the next articles are maybe not open access.
International Journal of Pharmaceutics, 2009
The objective of this work was to examine the physicochemical properties of spray dried budesonide, formoterol fumarate and their mixtures at two different weight ratios: 100:6 and 400:6 of budesonide and formoterol fumarate, respectively. A comparison of the thermal properties, crystalline/amorphous nature and particle size of the starting micronised ...
L, Tajber +3 more
openaire +2 more sources
The objective of this work was to examine the physicochemical properties of spray dried budesonide, formoterol fumarate and their mixtures at two different weight ratios: 100:6 and 400:6 of budesonide and formoterol fumarate, respectively. A comparison of the thermal properties, crystalline/amorphous nature and particle size of the starting micronised ...
L, Tajber +3 more
openaire +2 more sources
Arzneimittelforschung, 2011
This paper deals with a crossover trial on healthy volunteers performed to obtain combined pharmacodynamic, safety and pharmacokinetic data in order to assess the bioequivalence of formoterol fumarate (CAS 43229-80-7) delivered by mono-dose dry powder inhalers, as test and reference.
MARZO A +8 more
openaire +3 more sources
This paper deals with a crossover trial on healthy volunteers performed to obtain combined pharmacodynamic, safety and pharmacokinetic data in order to assess the bioequivalence of formoterol fumarate (CAS 43229-80-7) delivered by mono-dose dry powder inhalers, as test and reference.
MARZO A +8 more
openaire +3 more sources
Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
Expert Review of Respiratory Medicine, 2014A new combination inhaler containing fluticasone, a potent inhaled corticosteroid (ICS), and formoterol, a long-acting β-agonist (LABA) with rapid onset and sustained bronchodilator effect, has been approved for treatment of persistent asthma in patients ≥12 years of age requiring combination ICS-LABA therapy.
David, Price, Elizabeth V, Hillyer
openaire +2 more sources
Fluticasone Propionate/Formoterol Fumarate: A Review of Its Use in Persistent Asthma
Drugs, 2013The corticosteroid fluticasone propionate (fluticasone) and the long-acting β₂-adrenoceptor agonist formoterol fumarate (formoterol) have been combined in a single, pressurized, metered-dose, aerosol inhaler for the maintenance treatment of patients aged ≥12 years with persistent asthma.
openaire +2 more sources
Expert Review of Respiratory Medicine, 2016
Inhaled therapy is often considered the cornerstone of asthma management and international guidelines recommend combination therapy of inhaled corticosteroids (ICS) and long-acting-beta2-agonists (LABA) in a large proportion of asthmatic patients. The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique,
CRISAFULLI, Ernesto +6 more
openaire +3 more sources
Inhaled therapy is often considered the cornerstone of asthma management and international guidelines recommend combination therapy of inhaled corticosteroids (ICS) and long-acting-beta2-agonists (LABA) in a large proportion of asthmatic patients. The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique,
CRISAFULLI, Ernesto +6 more
openaire +3 more sources
Disposition and metabolism of formoterol fumarate, a new bronchodilator, in rats and dogs
Xenobiotica, 19821. The disposition and metabolism of formoterol fumarate, a highly potent beta 2-adrenoceptor stimulant, were studied in rats and dogs. 2. After oral administration of [3H] formoterol fumarate to dogs, unchanged formoterol accounted for greater than 60% of the plasma radioactivity immediately after dosage; greater than 20% was due to the unchanged drug
H, Sasaki +5 more
openaire +2 more sources
Pharmacokinetics and effects of formoterol fumarate in healthy human subjects after oral dosing
European Journal of Clinical Pharmacology, 1998To evaluate the effects of formoterol after oral administration on plasma eosinophils and plasma potassium in healthy subjects.Plasma concentrations of formoterol, peripheral eosinophil count and plasma potassium were determined during 7 h after oral administration of 168 microg of formoterol to eight healthy subjects. Descriptions of the concentration-
B T, van den Berg +2 more
openaire +2 more sources
Journal of the Chemical Society of Pakistan
Dry powder inhalers (DPIs) have been well established and recognized for the delivery to the lungs. It provides better drug stability, less irritable, easy to use with deep penetration of drugs in the lungs.
Affan Ali Affan Ali +2 more
semanticscholar +1 more source
Dry powder inhalers (DPIs) have been well established and recognized for the delivery to the lungs. It provides better drug stability, less irritable, easy to use with deep penetration of drugs in the lungs.
Affan Ali Affan Ali +2 more
semanticscholar +1 more source
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002
openaire +3 more sources
openaire +3 more sources

